Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 180272, 8 pages
http://dx.doi.org/10.1155/2012/180272
Review Article

Cell Death Mechanisms at the Maternal-Fetal Interface: Insights into the Role of Granulysin

1Department of Physiology and Immunology, Medical Faculty, University of Rijeka, 51000 Rijeka, Croatia
2Department of Radiology, Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia
3Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University Vienna, 1090 Vienna, Austria

Received 31 May 2011; Revised 12 July 2011; Accepted 12 July 2011

Academic Editor: Andres Salumets

Copyright © 2012 Danijela Veljkovic Vujaklija et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Red-Horse, Y. Zhou, O. Genbacev et al., “Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface,” Journal of Clinical Investigation, vol. 114, no. 6, pp. 744–754, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Le Bouteiller and M.-P. Piccinni, “Human NK cells in pregnant uterus: why there?” The American Journal of Reproductive Immunology, vol. 59, no. 5, pp. 401–406, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. Trundley and A. Moffett, “Human uterine leukocytes and pregnancy,” Tissue Antigens, vol. 63, no. 1, pp. 1–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. T. B. Crncic, G. Laskarin, K. Juretic et al., “Perforin and Fas/FasL cytolytic pathways at the maternal-fetal interface,” The American Journal of Reproductive Immunology, vol. 54, no. 5, pp. 241–248, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. L. Chávez-Galán, M. C. Arenas-Del Angel, E. Zenteno, R. Chávez, and R. Lascurain, “Cell death mechanisms induced by cytotoxic lymphocytes,” Cellular and Molecular Immunology, vol. 6, no. 1, pp. 15–25, 2009. View at Google Scholar · View at Scopus
  6. J. A. Trapani and M. J. Smyth, “Functional significance of the perforin/granzyme cell death pathway,” Nature Reviews Immunology, vol. 2, no. 10, pp. 735–747, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. M. E. Pipkin and J. Lieberman, “Delivering the kiss of death: progress on understanding how perforin works,” Current Opinion in Immunology, vol. 19, no. 3, pp. 301–308, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. B. Motyka, G. Korbutt, M. J. Pinkoski et al., “Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis,” Cell, vol. 103, no. 3, pp. 491–500, 2000. View at Google Scholar · View at Scopus
  9. S. Stenger, D. A. Hanson, R. Teitelbaum et al., “An antimicrobial activity of cytolytic T cells mediated by granulysin,” Science, vol. 282, no. 5386, pp. 121–125, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Rukavina and E. R. Podack, “Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant?” Immunology Today, vol. 21, no. 4, pp. 160–163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Rukavina and G. Vince, “Roles of cytokines and immune cells at the interface—a workshop report,” Placenta, vol. 21, supplement A, pp. S97–S98, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Rukavina, G. Rubesa, L. Gudelj, H. Haller, and E. R. Podack, “Characteristics of perforin expressing lymphocytes within the first trimester decidua of human pregnancy,” The American Journal of Reproductive Immunology, vol. 33, no. 5, pp. 394–404, 1995. View at Google Scholar · View at Scopus
  13. A. King, C. Birkby, and Y. W. Loke, “Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast,” Cellular Immunology, vol. 118, no. 2, pp. 337–344, 1989. View at Google Scholar · View at Scopus
  14. A. King and Y. W. Loke, “Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2 stimulated decidual NK cells,” Cellular Immunology, vol. 129, no. 2, pp. 435–448, 1990. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Strbo, G. Laskarin, T. B. Crncic et al., “Short-term cytolytic mediators' expression in decidual lymphocytes is enhanced by interleukin-15,” The American Journal of Reproductive Immunology, vol. 55, no. 3, pp. 217–225, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. G. Laskarin, N. Strbo, T. B. Crncic et al., “Physiological role of IL-15 and IL-18 at the maternal-fetal interface,” Chemical Immunology and Allergy, vol. 89, pp. 10–25, 2005. View at Google Scholar · View at Scopus
  17. Y. Hyodo, K. Matsui, N. Hayashi et al., “IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor,” Journal of Immunology, vol. 162, no. 3, pp. 1662–1668, 1999. View at Google Scholar · View at Scopus
  18. G. Laškarin, N. Štrbo, V. Sotošek et al., “Progesterone directly and indirectly affects perforin expression in cytolytic cells,” The American Journal of Reproductive Immunology, vol. 42, no. 5, pp. 312–320, 1999. View at Google Scholar
  19. L. Moretta, C. Bottino, D. Pende, M. Vitale, M. C. Mingari, and A. Moretta, “Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis,” Immunology Letters, vol. 100, no. 1, pp. 7–13, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. J. Hanna and O. Mandelboim, “When killers become builders,” Trends in Immunology, vol. 28, no. 5, pp. 201–206, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. R. Apps, S. P. Murphy, R. Fernando, L. Gardner, T. Ahad, and A. Moffett, “Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies,” Immunology, vol. 127, no. 1, pp. 26–39, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. H. El Costa, J. Tabiasco, A. Berrebi et al., “Effector functions of human decidual NK cells in healthy early pregnancy are dependent on the specific engagement of natural cytotoxicity receptors,” Journal of Reproductive Immunology, vol. 82, no. 2, pp. 142–147, 2009. View at Google Scholar · View at Scopus
  23. H. El Costa, A. Casemayou, M. Aguerre-Girr et al., “Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancy,” Journal of Immunology, vol. 181, no. 5, pp. 3009–3017, 2008. View at Google Scholar · View at Scopus
  24. J. Tabiasco, M. Rabot, M. Aguerre-Girr et al., “Human decidual NK cells: unique phenotype and functional properties—a review,” Placenta, vol. 27, supplement A, pp. 34–39, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. P. B. Stranges, J. Watson, C. J. Cooper et al., “Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity,” Immunity, vol. 26, no. 5, pp. 629–641, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. S. Nagata and P. Golstein, “The Fas death factor,” Science, vol. 267, no. 5203, pp. 1449–1456, 1995. View at Google Scholar · View at Scopus
  27. E. J. Blott, G. Bossi, R. Clark, M. Zvelebil, and G. M. Griffiths, “Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail,” Journal of Cell Science, vol. 114, no. 13, pp. 2405–2416, 2001. View at Google Scholar · View at Scopus
  28. T. B. Crncic, G. Laskarin, K. J. Frankovic et al., “Early pregnancy decidual lymphocytes beside perforin use Fas ligand (FasL) mediated cytotoxicity,” Journal of Reproductive Immunology, vol. 73, no. 2, pp. 108–117, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. A. Hammer and G. Dohr, “Expression of Fas-ligand in first trimester and term human placental villi,” Journal of Reproductive Immunology, vol. 46, no. 2, pp. 83–90, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Aschkenazi, S. Straszewski, K. M. Verwer, H. Foellmer, T. Rutherford, and G. Mor, “Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells,” Biology of Reproduction, vol. 66, no. 6, pp. 1853–1861, 2002. View at Google Scholar · View at Scopus
  31. M. Jerzak and P. Bischof, “Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling,” The European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 100, no. 2, pp. 138–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Bai, J. L. Williams, S. L. Greenwood, P. N. Baker, J. D. Aplin, and I. P. Crocker, “A placental protective role for trophoblast-derived TNF-related apoptosis-inducing ligand (TRAIL),” Placenta, vol. 30, no. 10, pp. 855–860, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. A. Siano, G. Tonarelli, M. S. Imaz et al., “Bactericidal and hemolytic activities of synthetic peptides derived from granulysin,” Protein and Peptide Letters, vol. 17, no. 4, pp. 517–521, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. W. C. Manning, S. O'Farrell, T. J. Goralski, and A. M. Krensky, “Genomic structure and alternative splicing of 519, a gene expressed late after T cell activation,” Journal of Immunology, vol. 148, no. 12, pp. 4036–4042, 1992. View at Google Scholar · View at Scopus
  35. D. A. Hanson, A. A. Kaspar, F. R. Poulain, and A. M. Krensky, “Biosynthesis of granulysin, a novel cytolytic molecule,” Molecular Immunology, vol. 36, no. 7, pp. 413–422, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. W. H. Chung, S. I. Hung, J. Y. Yang et al., “Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis,” Nature Medicine, vol. 14, no. 12, pp. 1343–1350, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. S. V. Peña, D. A. Hanson, B. A. Carr, T. J. Goralski, and A. M. Krensky, “Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins,” Journal of Immunology, vol. 158, no. 6, pp. 2680–2688, 1997. View at Google Scholar · View at Scopus
  38. J. L. Gansert, V. Kießler, M. Engele et al., “Human NKT cells express granulysin and exhibit antimycobacterial activity,” Journal of Immunology, vol. 170, no. 6, pp. 3154–3161, 2003. View at Google Scholar · View at Scopus
  39. L. Mincheva-Nilsson, O. Nagaeva, K. G. Sundqvist, M. L. Hammarström, S. Hammarström, and V. Baranov, “γδ T cells of human early pregnancy decidua: evidence for cytotoxic potency,” International Immunology, vol. 12, no. 5, pp. 585–596, 2000. View at Google Scholar · View at Scopus
  40. F. Dieli, M. Troye-Blomberg, J. Ivanyi et al., “Granulysin dependent killing of intacellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes,” Journal of Infectious Diseases, vol. 184, no. 8, pp. 1082–1085, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. D. H. Anderson, M. R. Sawaya, D. Cascio et al., “Granulysin crystal structure and a structure-derived lytic mechanism,” Journal of Molecular Biology, vol. 325, no. 2, pp. 355–365, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. A. M. Krensky and C. Clayberger, “Biology and clinical relevance of granulysin,” Tissue Antigens, vol. 73, no. 3, pp. 193–198, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. Z. Wang, E. Choice, A. Kaspar et al., “Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin,” Journal of Immunology, vol. 165, no. 3, pp. 1486–1490, 2000. View at Google Scholar · View at Scopus
  44. W. A. Ernst, S. Thoma-Uszynski, R. Teitelbaum et al., “Granulysin, a T cell product, kills bacteria by altering membrane permeability,” Journal of Immunology, vol. 165, no. 12, pp. 7102–7108, 2000. View at Google Scholar · View at Scopus
  45. H. Barman, M. Walch, S. Latinovic-Golic et al., “Cholesterol in negatively charged lipid bilayers modulates the effect of the antimicrobial protein granulysin,” Journal of Membrane Biology, vol. 212, no. 1, pp. 29–39, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. M. Walch, E. Eppler, C. Dumrese, H. Barman, P. Groscurth, and U. Ziegler, “Uptake of granulysin via lipid rafts leads to lysis of intracellular Listeria innocua,” Journal of Immunology, vol. 174, no. 7, pp. 4220–4227, 2005. View at Google Scholar · View at Scopus
  47. M. Walch, S. Latinovic-Golic, A. Velic et al., “Perforin enhances the granulysin-induced lysis of Listeria innocua in human dendritic cells,” BMC Immunology, vol. 8, article 14, 2007. View at Publisher · View at Google Scholar · View at PubMed
  48. S. Gamen, D. A. Hanson, A. Kaspar, J. Naval, A. M. Krensky, and A. Anel, “Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways,” Journal of Immunology, vol. 161, no. 4, pp. 1758–1764, 1998. View at Google Scholar · View at Scopus
  49. S. Okada, Q. Li, J. C. Whitin, C. Clayberger, and A. M. Krensky, “Intracellular mediators of granulysin-induced cell death,” Journal of Immunology, vol. 171, no. 5, pp. 2556–2562, 2003. View at Google Scholar · View at Scopus
  50. R. V. Saini, C. Wilson, M. W. Finn, T. Wang, A. M. Krensky, and C. Clayberger, “Granulysin delivered by cytotoxic cells damages endoplasmic reticulum and activates caspase-7 in target cells,” Journal of Immunology, vol. 186, no. 6, pp. 3497–3504, 2011. View at Publisher · View at Google Scholar · View at PubMed
  51. A. A. Kaspar, S. Okada, J. Kumar et al., “A distinct pathway of cell-mediated apoptosis initiated by granulysin,” Journal of Immunology, vol. 167, no. 1, pp. 350–356, 2001. View at Google Scholar · View at Scopus
  52. Q. Li, C. Dong, A. Deng et al., “Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 1, pp. 388–397, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. J. Pardo, P. Pérez-Galán, S. Gamen et al., “A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis,” Journal of Immunology, vol. 167, no. 3, pp. 1222–1229, 2001. View at Google Scholar · View at Scopus
  54. C. Clayberger and A. M. Krensky, “Granulysin,” Current Opinion in Immunology, vol. 15, no. 5, pp. 560–565, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Tewary, D. Yang, G. de la Rosa et al., “Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin,” Blood, vol. 116, no. 18, pp. 3465–3474, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. A. Deng, S. Chen, Q. Li, S. C. Lyu, C. Clayberger, and A. M. Krensky, “Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator,” Journal of Immunology, vol. 174, no. 9, pp. 5243–5248, 2005. View at Google Scholar · View at Scopus
  57. L. Castiello, D. F. Stroncek, M. W. Finn et al., “15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level,” Journal of Translational Medicine, vol. 9, article 41, 2011. View at Publisher · View at Google Scholar · View at PubMed
  58. L. Zitvogel and K. Guido, “The multifaceted granulysin,” Blood, vol. 116, no. 18, pp. 3379–3380, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. A. Hata, L. Zerboni, M. Sommer et al., “Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells,” Viral Immunology, vol. 14, no. 2, pp. 125–133, 2001. View at Google Scholar · View at Scopus
  60. D. C. Fleming, A. E. King, A. E. W. Williams, H. O. Critchley, and R. W. Kelly, “Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium,” Fertility and Sterility, vol. 79, no. 4, pp. 856–863, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Hameed, W. M. Fox, R. J. Kurman, R. H. Hruban, and E. R. Podack, “Perforin expression in endometrium during the menstrual cycle,” International Journal of Gynecological Pathology, vol. 14, no. 2, pp. 143–150, 1995. View at Google Scholar · View at Scopus
  62. V. D. Winn, R. Haimov-Kochman, A. C. Paquet et al., “Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term,” Endocrinology, vol. 148, no. 3, pp. 1059–1079, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. S. C. Lobo, S. T. J. Huang, A. Germeyer et al., “The immune environment in human endometrium during the window of implantation,” The American Journal of Reproductive Immunology, vol. 52, no. 4, pp. 244–251, 2004. View at Google Scholar · View at Scopus
  64. D. Veljkovic Vujaklija, T. Gulic, S. Sucic et al., “First trimester pregnancy decidual natural killer cells contain and spontaneously release high quantities of granulysin,” The American Journal of Reproductive Immunology. In press. View at Publisher · View at Google Scholar · View at PubMed
  65. G. Laskarin, A. Redzovic, P. Vukelic et al., “Phenotype of NK cells and cytotoxic/apoptotic mediators expression in ectopic pregnancy,” The American Journal of Reproductive Immunology, vol. 64, no. 5, pp. 347–358, 2010. View at Google Scholar
  66. S. Latinovic-Golic, M. Walch, H. Sundstrom, C. Dumrese, P. Groscurth, and U. Ziegler, “Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes,” BMC Immunology, vol. 8, article 9, 2007. View at Publisher · View at Google Scholar · View at PubMed
  67. L. P. Huang, S. C. Lyu, C. Clayberger, and A. M. Krensky, “Granulysin-mediated tumor rejection in transgenic mice,” Journal of Immunology, vol. 178, no. 1, pp. 77–84, 2007. View at Google Scholar · View at Scopus
  68. K. Ogawa, Y. Takamori, K. Suzuki et al., “Granulysin in human serum as a marker of cell-mediated immunity,” The European Journal of Immunology, vol. 33, no. 7, pp. 1925–1933, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. M. Sakai, K. Ogawa, A. Shiozaki et al., “Serum granulysin is a marker for Th1 type immunity in pre-eclampsia,” Clinical and Experimental Immunology, vol. 136, no. 1, pp. 114–119, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. B. Larsen and J. Hwang, “Mycoplasma, ureaplasma, and adverse pregnancy outcomes: a fresh look,” Infectious Diseases in Obstetrics and Gynecology, vol. 2010, Article ID 521921, 7 pages, 2010. View at Publisher · View at Google Scholar · View at PubMed
  71. E. Marks, M. A. Tam, and N. Y. Lycke, “The female lower genital tract is a privileged compartment with IL-10 producing dendritic cells and poor Th1 immunity following Chlamydia trachomatis infection,” PLoS Pathogens, vol. 6, no. 11, article e1001179, 2010. View at Publisher · View at Google Scholar · View at PubMed
  72. N. Langer, D. Beach, and E. S. Lindenbaum, “Novel hyperactive mitogen to endothelial cells: human decidual NKG5,” The American Journal of Reproductive Immunology, vol. 42, no. 5, pp. 263–272, 1999. View at Google Scholar · View at Scopus
  73. A. Nakashima, A. Shiozaki, S. Myojo et al., “Granulysin produced by uterine natural killer cells induces apoptosis of extravillous trophoblasts in spontaneous abortion,” The American Journal of Pathology, vol. 173, no. 3, pp. 653–664, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. A. Moffett, L. Regan, and P. Braude, “Natural killer cells, miscarriage, and infertility,” The British Medical Journal, vol. 329, no. 7477, pp. 1283–1285, 2004. View at Google Scholar · View at Scopus
  75. P. Le Bouteiller, J. Tabiasco, and J. Parinaud, “Soluble HLA-G and embryo implantation: frequently asked questions,” Gynecologic and Obstetric Investigation, vol. 64, no. 3, pp. 134–137, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. N. Rouas-Freiss, R. M. Gonçalves, C. Menier, J. Dausset, and E. D. Carosella, “Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 21, pp. 11520–11525, 1997. View at Publisher · View at Google Scholar · View at Scopus